Kanser Tedavisi İçin Yatan Hastalarda Malnütrisyonun Antropometrik Ölçümler ve Kas Fonksiyonlarına Etkisi

Amaç: Kanserde malnütrisyon, tümörden ya da tedavilerden kaynaklanan etkiler nedeniyle sık görülür. Bu çalışmanınamacı onkoloji kliniğinde yatan hastaların nütrisyonel durumlarını saptamak ve malnütrisyonun antropometrik ölçümler,kas fonksiyonları ve hastanede yatış süreleri üzerindeki etkisini değerlendirmektir.Bireyler ve Yöntem: Bu prospektif, gözlemsel çalışma Ege Üniversitesi Hastanesi, Onkoloji kliniğinde yatan, yaş ortalaması51.7±16.3 yıl olan, 422 hasta (%49.1’i erkek, %50.9’u kadın) ile gerçekleştirilmiştir. Hastalara Nütrisyonel Risk Taraması (NRS-2002) yapılmış, skorun ≥3 olması malnütrisyonlu ya da malnütrisyon riski altında olarak değerlendirilmiştir. Hastalarınbeden kütle indeksi (BKİ), üst orta kol çevresi (ÜOKÇ), baldır çevresi (BÇ), el kavrama gücü ölçülmüş, günlük enerji veprotein alımları, aldıkları beslenme tedavileri ile hastanede yattıkları gün sayısı kaydedilmiştir.Bulgular: Hastaların %68.5’inin NRS-2002 skoru ≥3, %17.1’inin BKİ’si ≤18.5 kg/m2 olarak bulunmuştur. Hastaların %72.7’sitanı öncesinde ya da sonrasında vücut ağırlığı kaybetmiş, bunların %47.9’u >%10 vücut ağırlığı kaybetmiştir. El kavramagücü erkeklerde

The Effect of Malnutrition on Anthropometric Measurements and Muscle Functions in Hospitalized Patients with Cancer Treatment

Aim: The aim of this study was to determine the nutritional status of patients with cancer and to determine whether malnutrition had an effect on anthropometric measurements, muscle functions and hospitalization days (HD). Subject and Methods: This prospective, observational study was carried out with 422 oncology inpatients (male 49.1% and 50.9% female, mean 51.7±16.3 years). The Nutritional Risk Screening (NRS-2002) score ≥3 was considered to be in malnutrition or at risk. Body mass index (BMI), upper mid-arm circumference (MUAC), calf circumference (CC), hand grip strength (HGS), energy and protein intake, HD and nutritional treatments of the patients were recorded. Results: NRS-2002 scores were ≥3 in 68.5% and BMI ≤18.5 in 17.1% of patients, 72.7% of the patients lost body weight, 47.9% of them lost >10%. It was found that 67.4% of females had HGS

PDF

___

1. Mattox TW. Cancer cachexia: Cause, diagnosis, and treatment. Nutr Clin Pract. 2017;32(5):599-606.
2. Ryan AM, Power DG, Daly L, Cushen SJ, Ni Bhuachalla E, Prado CM. Cancer-associated malnutrition, cachexia and sarcopenia: The skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75:1–13.
3. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.
4. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.
5. Ryan A, Power D, Daly L, Cushen S, Ní Bhuachalla Ē, Prado C. Cancer-associated malnutrition, cachexia and sarcopenia: The skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199-211.
6. Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical value of nutritional status in cancer: What is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151-76.
7. Aaldriks AA, van der Geest LG, Giltay EJ, le Cessie S, Portielje JE, Tanis BC, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4:218–26.
8. Gellrich NC, Handschel J, Holtmann H, Kruskemper G. Oral cancer malnutrition impacts weight and quality of life. Nutrients. 2015;7:2145–60.
9. Prado CM, Cushen SJ, Orsso CE, Ryan AM. Sarcopenia and cachexia in the era of obesity: Clinical and nutritional impact. Proc Nutr Soc. 2016;75:1–11.
10. Ravasco P. Nutrition in Cancer Patients. J Clin Med. 2019;14:8(8):1211. Available from: doi: 10.3390/ jcm8081211.
11. Hebuterne X, Lemarie E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN. 2014;38:196–204.
12. Planas M, Alvarez-Hernandez J, Leon-Sanz M, Celaya- Perez S, Araujo K, Garcia de Lorenzo A, et al. Prevalence of hospital malnutrition in cancer patients: A subanalysis of the PREDyCES® study. Support Care Cancer. 2016;24:429–35.
13. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, ESPEN Ad Hoc Working G. Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321–36.
14. Reber E, Gomes F, Vasiloglou MF, Schuetz P, Stanga Z. Nutritional risk screening and assessment. J Clin Med. 2019;20:8(7): 1065. Available from: doi: 10.3390/ jcm8071065.
15. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–21.
16. Pekcan G. Beslenme Durumunun Saptanması. Ankara: Klasmat Matbaacılık; 2008. s.13-21
17. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European working group on sarcopenia in older people, sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412-23.
18. Na BG, Han SS, Cho YA, Wie GA, Kim JY, Lee JM, Lee SD, et al. Nutritional status of patients with cancer: A prospective cohort study of 1,588 hospitalized patients. Nutr Cancer. 2018;70(8):1228-36.
19. Stene GB, Helbostad JL, Amundsen T, Sørhaug S, Hjelde H, Kaasa S, Grønberg BH. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54(3):340-8.
20. Orell-Kotikangas H, Österlund P, Mäkitie O, Saarilahti K, Ravasco P, Schwab U, et al. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients. Acta Otolaryngol. 2017;137(7):778-85.
21. Jeejeebhoy KN. Nutritional assessment. Nutrition. 2000;16(7-8):585-90.
22. Luna-Heredia E, Martin-Pena G, Ruiz-Galiana J. Handgrip dynamometry in healthy adults. Clin Nutr. 2005;24:250-58.
23. Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P. Muscle dysfunction in cancer patients. Ann Oncol. 2014;25(5):947-58.
24. Norman K, Schutz T, Kemps M, Josef LH, Lochs H, Pirlich M. The Subjective Global Assessment reliably identifies malnutrition-related muscle dysfunction. Clin Nutr. 2005;24:143-50.
25. Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90-9.
26. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A populationbased study. Lancet Oncol. 2008;9:629–35.
27. Hopancı Bıçaklı D, Çehreli R, Özveren A, Meseri R, Uslu, R, Uyar M. et al. Evaluation of sarcopenia, sarcopenic obesity, and phase angle in geriatric gastrointestinal cancer patients: Before and after chemotherapy. Turk J Med Sci. 2019;49(2):583-8.
28. Cong M, Wang J, Fang Y, Liu Y, Sun M, Wu Q, et al. A multi-center survey on dietary knowledge and behavior among inpatients in oncology department. Support Care Cancer. 2018;26(7):2285-92.
29. Cotogni P, Pedrazzoli P, De Waele E, Aprile G, Farina G, Stragliotto S, et al. Nutritional therapy in cancer patients receiving chemoradiotherapy: Should we need stronger recommendations to act for improving outcomes? J Cancer. 2019;10(18):4318–25 . 30. Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187-96.
31. Muscaritoli M, Costelli P, Aversa Z, Bonetto A, Baccino FM, FR Fanelli. New strategies to overcome cancer cachexia: From molecular mechanisms to the ‘Parallel Pathway’. Asia Pac J Clin Nutr. 2008;17(S1):387-90.